Henry Sobo, MD Holistic & Integrative Medicine, Stamford, Connecticut Peptide Therapy for Weight Loss in Connecticut: AOD-9604, Tesamorelin & Beyond In Stamford and across Connecticut, many patients are asking about peptide therapy as a newer tool for medically supervised weight loss and metabolic health, especially as they hear about options like AOD9604, tesamorelin, and GLP1 medications
Subcutaneous (into the fat just under the skin)
AOD-9604 is named explicitly on the WADA 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times both in-competition and out-of-competition for all athletes under WADA jurisdiction
Track and Adjust : Maintain a log of your doses, timing, and results
Archived from the original on June 27, 2010
What is 5-Amino-1MQ